Skip to Content
Merck
  • An injury-responsive Rac-to-Rho GTPase switch drives activation of muscle stem cells through rapid cytoskeletal remodeling.

An injury-responsive Rac-to-Rho GTPase switch drives activation of muscle stem cells through rapid cytoskeletal remodeling.

Cell stem cell (2022-05-22)
Allison P Kann, Margaret Hung, Wei Wang, Jo Nguyen, Penney M Gilbert, Zhuhao Wu, Robert S Krauss
ABSTRACT

Many tissues harbor quiescent stem cells that are activated upon injury, subsequently proliferating and differentiating to repair tissue damage. Mechanisms by which stem cells sense injury and transition from quiescence to activation, however, remain largely unknown. Resident skeletal muscle stem cells (MuSCs) are essential orchestrators of muscle regeneration and repair. Here, with a combination of in vivo and ex vivo approaches, we show that quiescent MuSCs have elaborate, Rac GTPase-promoted cytoplasmic projections that respond to injury via the upregulation of Rho/ROCK signaling, facilitating projection retraction and driving downstream activation events. These early events involve rapid cytoskeletal rearrangements and occur independently of exogenous growth factors. This mechanism is conserved across a broad range of MuSC activation models, including injury, disease, and genetic loss of quiescence. Our results redefine MuSC activation and present a central mechanism by which quiescent stem cells initiate responses to injury.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
CCG-203971, ≥98% (HPLC)
Sigma-Aldrich
(−)-Blebbistatin, solid, synthetic
Sigma-Aldrich
Anti-Laminin antibody produced in rabbit, 0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-ARP3 antibody, Mouse monoclonal, clone FMS338, purified from hybridoma cell culture
Sigma-Aldrich
Tamoxifen, ≥99%
Sigma-Aldrich
NSC23766 trihydrochloride, ≥97% (HPLC)